CRNLF(CRNLF)
CRNLF
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $954M | $1.49B | $2.07B | $2.14B |
| Low | $859M | $1.34B | $1.86B | $1.93B |
| High | $1.07B | $1.68B | $2.33B | $2.41B |
| EBITDA Avg | $179M | $280M | $388M | $402M |
| Low | $161M | $252M | $350M | $362M |
| High | $202M | $315M | $438M | $453M |
| EBIT Avg | $125M | $195M | $271M | $280M |
| Low | $113M | $176M | $244M | $252M |
| High | $141M | $220M | $305M | $316M |
| Net Income Avg | $393M | $621M | $820M | $837M |
| Low | $342M | $541M | $714M | $729M |
| High | $457M | $723M | $955M | $975M |
| EPS Avg | $0.97 | $1.53 | $2.02 | $2.06 |
| Low | $0.84 | $1.33 | $1.76 | $1.79 |
| High | $1.12 | $1.78 | $2.35 | $2.40 |
| Analysts (Rev / EPS) | 8 / 1 | 5 / 1 | 6 / 1 | 6 / 1 |